Procurement Summary
Country : USA
Summary : CDI Laboratories HuProt v4.0 Human Proteome Microarrays (100) with Biospecimen Screening Service and Analysis
Deadline : 11 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 115930413
Document Ref. No. : 75N95025Q00167
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
(1) This is a combined synopsis/solicitation for commercial products and/or commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(2) The solicitation number is 75N95025Q00167 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial product and commercial services and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services, and is not expected to exceed the simplified acquisition threshold.
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute of Mental Health (NIMH), intends to negotiate and award a purchase order without providing for full and open competition (including brand name) to CDI Laboratories Inc., 12 Oeste Calle Mandez Vigo, Mayaguez, PR 00680-4983 for HuProt™ v4.0 Human Proteome Microarrays with Biospecimen Screening Service and Analysis.
This acquisition is conducted as non-competitive for a commercial product or commercial service and is conducted pursuant to FAR 13.106-1(b)(1).
(3) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-03, with effective date January 17, 2025.
(4) The associated NAICS code is 541380 and the small business size standard is $19 million.
(5) This requirement is for the following: HuProt™ v4.0 Human Proteome Micr...
Active Contract Opportunity
Notice ID : 75N95025Q00167
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Mar 07, 2025 08:34 pm EST
Original Date Offers Due: Mar 11, 2025 09:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Mar 26, 2025
Initiative: None
Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services
Place of Performance: USA
Documents
Tender Notice
Attachment-Invoicing-Provisions-and-Instructions-W.pdf
Attachment-HHSAR-352.pdf
Attachment-FAR-52.pdf
Attachment-FAR-52.pdf
Attachment-FAR-52.pdf
Attachment-FAR-52.pdf
Purchase-Description_HuProt-Microarray-with-Servic.pdf